Sintomas de ansiedade e depressão em pessoas com doença de parkinson durante a pandemia de Covid-19
DOI:
https://doi.org/10.34119/bjhrv6n2-152Keywords:
Doença de Parkinson, Depressão, Ansiedade, pandemia, Covid-19Abstract
A Doença de Parkinson (DP) é uma doença neurodegenerativa progressiva, com sintomas motores e não motores. O quadro clínico do paciente com DP pode ser gravemente influenciado por circunstâncias geradores de estresse, como o isolamento social decorrente da pandemia. Foi realizado um estudo transversal no município de Presidente Prudente, São Paulo, em 2022, com o objetivo de avaliar a prevalência de sintomas de depressão e ansiedade nos pacientes com DP na pandemia de Covid-19, quando comparados com aqueles que não possuem a doença. Foram incluídos neste estudo 60 sujeitos, 30 com DP e 30 idosos sem desordens neurológicas. Foi avaliado o perfil sociodemografico e aplicada a Escala de Ansiedade e Depressão (HAD). Os resultados obtidos mostraram que não há diferença estatisticamente significativa, no tocante ao estado psicossocial, entre os grupos analisados, o que sustenta a conclusão de alguns estudos, mas também diverge dos resultados de outros, sendo necessárias novas análises com amostras maiores e ferramentas mais abrangentes.
References
ADHAKRISHNAN, D. M.; Goyal, V. Parkinson's disease: a review. Neurology India, v. 66, p. 26-35, 2018
REICH, S. G.; SAVITT, J. M. Parkinson Disease. Medical Clinics of North America, v. 103, p. 337-350, 2019.
DORSEY, E. R.; et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology, v. 17, p. 939–953, 2018.
BOVOLENTA, T. M.; CARVALHO FELICIO, A. O doente de Parkinson no contexto das Políticas Públicas de Saúde no Brasil. Revista Einstein, v. 14, p. 7-9, 2016.
SVEINBJORNSDOTTIR, S.The clinical symptoms of Parkinson’s disease. Journal of Neurochemistry, v. 139, p. 318–324, 2016.
HAYES, M. T. Parkinson’s disease and parkinsonism. The American Journal of Medicine, v. 132, p. 802-807, 2019.
MARSH, L. Depression and Parkinson’s Disease: Current Knowledge. Current Neurology and Neuroscience Reports 13, Article number 409, 2013.
WU, P.; et al. Effectiveness of physical activity on patients with depression and Parkinson’s desease: A systematic review. Plos One, p. 1-14, 2017.
SCHAPIRA, A. H. V.; et al. Non-motor features of Parkinson disease. Nature Reviews neuroscience, v. 18, p. 435-450, 2017.
JANIRI, D.; PETRACCA, M.; MOCCIA, L.; et al. COVID-19 Pandemic and psychiatric Symptoms: The impact n Parkinson’s Desease in the Elderly. Frontiers in Psychiatric, v. 11, p. 1-8, 2020.
KITANI-MORII, F.; KASAI, T.; HORIGUCHI, G. et al. Risk factors for neuropsychiatric symptoms in patients with Parkinson’s disease during COVID-19 pandemic in Japan. Plos one, p. 1-13, 2021.
HELMICH, R.; BLOEM, B. The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities. Journal of Parkinson’s Disease, v. 10, p. 351-354, 2020.
BALCI, B.; et al. Impact of the COVID-19 pandemic on physical activity, anxiety, and depression in patients with Parkinson's disease. International Journal of Rehabilitation Research, 2021.
OTMANI, H.; BIDAOUI, Z.; AMZIL, R.; et al. No impact of confinement during COVID-19 pandemic on anxiety an depression in Parkinsonian patients. Revue Neurologique, v. 177, p. 272-274, 2021.
LILL, C. M.; KLEIN, C. Epidemiologie und Ursachen der Parkinson-Erkrankung. Der Nervenarzt, v. 88, p. 345–355, 2017.
FARO, A. Análise fatorial confirmatória e normatização da Hospital Anxiety and Depression Scale (HADS). Psicologia: Teoria e Pesquisa, v. 31, p. 349-353, 2015.
SNAITH, R. The Hospital Anxiety and Depression Scale. BioMed Central, 2003.
SANTOS, G et al., Doença de Parkinson: Padrão epidemiológico das internações no Brasil. Research, Society and Development, v.11, n 1, 2022.
ASCHERIO, A.;SCHWARZSCHILD, M. The epidemiology of Parkinson’s Disease: Risk factors and prevention. The Lancet Neurology, v. 15, p. 1257-1272, 2016.
CRISPINO, P.; et al. Gender Differences and Quality of Life in Parkinson’s Disease. Int. International Journal of Environmental Research and Public Health, v. 18, p.198, 2021.
SCOTT, B.; et al. Gender differences in Parkinson’s disease symptom profile. Acta Neurolologica Scandinava, v. 102, p. 37–43, 2000.
PICILLO, M.; et al. Gender differences in non-motor symptoms in early Parkinson’s disease: A 2-years follow-up study on previously untreated patients. Parkinsonism Relat. Disord. v. 20, p. 850–854, 2014.
SONG, J.; et al.The changes of exercise pattern and clinical symptoms in patients with Parkinson’s disease in the era of COVID-19 pandemic. Parkinsonism Relat Disord v.80, p.148–151, 2020.
MAK, MK.; et al. Long-term effects of exercise and physical therapy in people with Parkinson disease. Nature Reviews Neurology, v.13, p. 689-703, 2017.
SCHIRINZI, T.; et al.Physical activity changes and correlate efects in patients with Parkinson’s disease during COVID-19 lockdown. Movement Disorders Clinical Practices, v. 7, p.797–802, 2020.
VEAZEY, C.;et al. Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson’s disease. Journal of Clinical Psychology in Medical Settings, v.16, p. 243-253, 2009.
SHALASH, et al. Mental Health, Physical Activity, and Quality of Life in Parkinson’s Disease During COVID-19 Pandemic. Movement Disorders, v. 35, 2020.
DEL PRETE, E et al. Prevalência e impacto do COVID-19 na doença de Parkinson: evidências de uma pesquisa multicêntrica na região da Toscana. Journal of Neurology, p. 1179-1187, 2021.
NABIZADEH, F.; et al. Resultados psicológicos da pandemia de COVID-19 em pacientes com doença de Parkinson: uma revisão sistemática. Journal of Clinical Neuroscience, v. 102, p. 101-108, 2022.
